REFERENCES
- Budde-Steffen C, Anderson N E, Rosenblum M K, et al. An antineuronal autoantibody in paraneoplastic opsoclonus. Ann Neurol 1988; 23: 528–531, [PUBMED], [INFOTRIEVE]
- Budde-Steffen C, Anderson N E, Rosenblum M K, Posner J B. Expression of an antigen in small cell lung carcinoma lines detected by antibodies from patients with paraneoplastic dorsal root ganglionpathy. Cancer Res 1988; 48: 430–434, [PUBMED], [INFOTRIEVE]
- Gazdar A F, Carbone D P. The biology and molecular genetics of lung cancer. R.G. Landes Company, CRC Press, Austin/Georgetown 1994
- Thirkill C E. Retinal autoantibodies. Autoantibodies, J B Peter, Y Shoenfeld. Elsevier, Amsterdam, Lausanne, New York, Oxford, Shannon, Tokyo 1997; 694–699
- Hildebrand J. Paraneoplastic syndromes. II. Neurological paraneoplasia. Eur J Cancer Clin Oncol 1981; 17(9)985–990, (Review)[PUBMED], [INFOTRIEVE]
- Rees J H, Hain S F, Johnson M R, et al. The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain 2001; 124(Pt 11)2223–2231, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dalmau J, Posner J B. Neurologic paraneoplastic antibodies (anti-Yo; anti-Hu; anti-Ri). Neurology 1994; 44: 2241–2246, [PUBMED], [INFOTRIEVE], [CSA]
- Peterson K, Rosenblum M K, Kotanides H, Posner J B. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients. Neurology 1992; 42: 1931–1937, [PUBMED], [INFOTRIEVE]
- Thirkill C E. Immunology of paraneoplastic syndromes. Immunology of ocular tumors, M Zierhut, M Jager, B Ksander. Aeolus Press/Swets & Zeitlinger, LisseThe Netherlands 2002; 237–254
- Ottinetti A, Colombo E, Dardano F, et al. Cutaneous metastasis of neuroendocrine carcinoma of the larynx: report of a case. J Cutan Pathol 2003; 30(8)512–515, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Weed J C, Jr, Graff A T, Shoup B, Tawfik O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 2003; 197(1)44–51, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Eichhorn J H, Young R H. Neuroendocrine tumors of the genital tract. Am J Clin Pathol 2001; 115(Suppl)S94–112, (Review)[PUBMED], [INFOTRIEVE]
- Posner J B, Dalmau J O. Yet another paraneoplastic antibody. Ann Neurol 2002; 49(2)141–142, [CROSSREF], [CSA]
- Posner J B, Dalmau J O. Paraneoplastic syndromes of the nervous system. Clin Chem Lab Med 2000; 38(2)117–122, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gultekin S H, Rosenfeld M R, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms; immunological findings and tumour association in 50 patients. Brain 2000; 123(Pt 7)1481–1494, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Keltner J L, Roth A M, Chang R S. Photoreceptor degeneration. Possible autoimmune disorder. Arch Ophthalmol 1983; 101: 564–569, [PUBMED], [INFOTRIEVE]
- Thirkill C E, Roth A M, Keltner J L. Cancer-associated retinopathy. Arch Ophthalmol 1987; 105: 372–375, [PUBMED], [INFOTRIEVE]
- Thirkill C E, FitzGerald P J, Sergott R C, et al. Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal; optic-nerve; and cancer cells. N Engl J Med 1989; 321: 1589–1594, [PUBMED], [INFOTRIEVE]
- Yoon Y H, Cho E H, Sohn J, Thirkill C E. An unusual type of cancer-associated retinopathy in a patient with ovarian cancer. Korean J Ophthalmol 1999; 13(1)43–48, [PUBMED], [INFOTRIEVE], [CSA]
- Rudge P. Optic neuritis as a complication of carcinoma of the breast. Proc R Soc Med 1973; 66: 1106–1107, [PUBMED], [INFOTRIEVE]
- Wilkinson P C, Zeromski J. Immunofluorescent detection of antibodies against neurones in sensory carcinomatous neuropathy. Brain 1965; 88(3)529–583, [PUBMED], [INFOTRIEVE]
- Zeromski J, Wilkinson P C. Immunological aspects of carcinomatous neuropathy: some observations on the nature of the neuronal antigen. Pathol Eur 1966; 1(1)298–310, [PUBMED], [INFOTRIEVE]
- Sawyer R A, Selhorst J B, Zimmerman L E, Hoyt W F. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol 1976; 81: 606–613, [PUBMED], [INFOTRIEVE]
- Kornguth S E, Kalinke T, Grunwald G B, et al. Anti-neurofilament antibodies in the sera of patients with small cell carcinoma of the lung and with visual paraneoplastic syndrome. Cancer Res 1986; 46: 2588–2595, [PUBMED], [INFOTRIEVE]
- Kornguth S E, Klein R, Appen R, Choate J. Occurrence of anti-retinal ganglion cell antibodies in patients with small cell carcinoma of the lung. Cancer 1982; 50: 1289–1293, [PUBMED], [INFOTRIEVE]
- Kornguth S E. Neuronal proteins and paraneoplastic syndromes. N Engl J Med 1989; 321: 1607–1608, [PUBMED], [INFOTRIEVE]
- Kornguth S E, Spear P E, Langer F. Reduction in numbers of large ganglion cells in cat retina following intravitreous injection of antibodies. Brain Res 1982; 245(1)35–45, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Klingele T G, Burde R M, Rappazzo J A, et al. Paraneoplastic retinopathy. J Clin Neuro-Ophthalmol 1984; 4: 239–245
- Grunwald G B, Klein R, Simmonds M A, Kornguth S E. Autoimmune basis for visual paraneoplastic syndrome in patients with small-cell lung carcinoma. Lancet 1985; 1: 658–661, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Grunwald G B, Kornguth S E, Towfighi J, et al. Autoimmune basis for visual paraneoplastic syndrome in patients with small cell lung carcinoma. Retinal immune deposits and ablation of retinal ganglion cells. Cancer 1987; 60: 780–786, [PUBMED], [INFOTRIEVE]
- Thirkill C E, Tait R C, Tyler N K, Roth A M, Keltner J L. The cancer connection: an antigen immunologically related to the retinal CAR antigen is expressed in small cell carcinoma of the lung. Proceedings of the Third International Symposium on Uveitis, J P Dernouchamps. Kugler Publications, Amsterdam/New York 1993; 133–135
- Polans A S, Witkowski D, Hayley T L, et al. Recoverin; a photoreceptor specific calcium-binding protein is expressed by the tumor of a patient with cancer-associated retinopathy. Proc Natl Acad Sci USA 1995; 92: 9176–9180, [PUBMED], [INFOTRIEVE], [CSA]
- Peek R, Verbraak F, Coevoet H, Kijlstra A. Muller cell-specific autoantibodies in a patient with progressive loss of vision. Invest Ophthalmol Vis Sci 1998; 39: 1976–1979, [PUBMED], [INFOTRIEVE], [CSA]
- Thirkill C E. Cancer associated retinopathy. The CAR syndrome. Neuro-Ophthalmology 1994; 14: 297–323
- Thirkill C E. Cancer-induced retinal hypersensitivity. Br J Biomed Sci 1996; 53(3)227–234, [PUBMED], [INFOTRIEVE], [CSA]
- Thirkill C E. Lung cancer-induced blindness. Lung Cancer 1996; 14: 253–264, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Honnorat J, Antoine J C. Value of detection of anti-nervous system autoantibodies in neurologic paraneoplastic syndromes. Rev Med Intern 1994; 15(2)124–133
- Sun J B. Autoreactive T and B cells in nervous system diseases. Acta Neurol Scand Suppl 1993; 142: 1–56, [PUBMED], [INFOTRIEVE]
- Becker M D, Adamus G, Davey M P, Rosenbaum J T. The role of T cells in autoimmune uveitis. Ocul Immunol Inflamm 2000; 8(2)93–100, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Adamus G, Machnicki M, Seigel G M. Apoptotic retinal cell death induced by antirecoverin autoantibodies of cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1997; 38(2)283–291, [PUBMED], [INFOTRIEVE], [CSA]
- Spear P D, Jones K R, Zetlan S R, et al. Effects of antibodies to large ganglion cells on the cat's retinogeniculate pathway. J Neurophysiol 1982; 47(6)1174–1195, [PUBMED], [INFOTRIEVE], [CSA]
- Williams R W, Crabtree J W, Chalupa L M, et al. Selectivity of antibody-mediated destruction of axons in the cat's optic nerve. Brain Res 1985; 336(1)57–66, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Spear P D, Miller S, Vielhuber K, Kornguth S E. Visual field defects in cats with neonatal or adult immunological loss of retinal ganglion cells. Brain Res 1986; 368(1)154–157, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Crabtree J W, Spear P D, McCall M A, et al. Contributions of Y- and W-cell pathways to response properties of cat superior colliculus neurons: comparison of antibody- and deprivation-induced alterations. J Neurophysiol 1986; 56(4)1157–1173, [PUBMED], [INFOTRIEVE], [CSA]
- Crabtree J W, Spear P D, McCall M A, et al. Dose-response analysis of effects of antibodies to large ganglion cells on the cat's retinogeniculate pathways. J Neurosci 1986; 6(5)1199–1210, [PUBMED], [INFOTRIEVE]
- Kornguth S, Auerbach R, Grieves J, Kahan L. Immunological reactivity of monoclonal antibodies prepared against large ganglion cells from bovine retina. Neurosci Lett 1981; 27(2)151–157, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Richman D P, Agius M A. Acquired myasthenia gravis: immunopathology. Neurol Clin 1994; 12(2)273–284, [PUBMED], [INFOTRIEVE]
- Adamus G, et al. Role of anti-recoverin autoantibodies in cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34: 2626–2633, [PUBMED], [INFOTRIEVE]
- Gery I, Mochizuki M, Nussenblatt R B. Retinal specific antigens and immunopathogenic processes they provoke. Prog Retin Res 1986; 5: 57–109
- Strebelow M, Schlosser M, Ziegler B, et al. Karlsburg type I diabetes risk study of a general population: frequencies and interactions of the four major type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 1999; 42(6)661–670, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354, [PUBMED], [INFOTRIEVE]
- Thirkill C E, Tait R C, Tyler N K, et al. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci 1992; 33(10)2768–2772, [PUBMED], [INFOTRIEVE]
- Milam A H, Dacey D M, Dizhoor A M. Recoverin immunoreactivity in mammalian cone bipolar cells. Vis Neurosci 1993; 10(1)1–12, [PUBMED], [INFOTRIEVE]
- Dizhoor A M, Ray S, Kumar S, et al. Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science 1991; 251: 915–918, [PUBMED], [INFOTRIEVE]
- Thirkill C E, Tait R C, Tyler N K, Roth A M, Keltner J L, et al. Intraperitoneal cultivation of small–cell carcinoma induces expression of the retinal cancer–associated retinopathy antigen. Arch Ophthalmol 1993; 111(7)974–978, [PUBMED], [INFOTRIEVE]
- Gregerson D S. Peripheral expression of ocular antigens in regulation and therapy of ocular autoimmunity. Int Rev Immunol 2002; 21(2–3)101–121, (Review)[PUBMED], [INFOTRIEVE], [CSA]
- Nussenblatt R B, et al. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol. 1990; 144(5)1689–1695, [PUBMED], [INFOTRIEVE]
- Nussenblatt R B, et al. Treatment of uveitis by oral administration of retinal antigens: results of a phase I/II randomized masked trial. Am J Ophthalmol 1997; 123(5)583–592, [PUBMED], [INFOTRIEVE], [CSA]
- Nussenblatt R B, et al. Intraocular inflammatory disease (uveitis) and the use of oral tolerance: a status report. Ann NY Acad Sci 1996; 778: 325–337, [PUBMED], [INFOTRIEVE], [CSA]
- De Smet M D, Chan C C. Regulation of ocular inflammation: what experimental and human studies have taught us. Prog Retin Eye Res 2001; 20(6)761–797, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Polans A S, Buczylko J, Crabb J, Palczewski K. A photoreceptor calcium binding protein is recognized by autoantibodies obtained from patients with cancer-associated retinopathy. J Cell Biol 1991; 112: 981–989, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Donoso L A, Rodrigues M, Vrabec T R, et al. IRBP: preparation and characterization of site-specific monoclonal antibodies. Curr Eye Res 1990; 9: 357–362, [PUBMED], [INFOTRIEVE]
- Donoso L A, Rorke L B, Shields J A, et al. S-antigen immunoreactivity in trilateral retinoblastoma. Am J Ophthalmol 1987; 103: 57–62, [PUBMED], [INFOTRIEVE], [CSA]
- Adamus G, et al. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats. Exp Eye Res 1994; 59: 447–456, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Igal Gery Chanaud N P, Anglade E. Recoverin is highly uveitogenic in Lewis rats. Invest Ophthalmol Vis Sci 1994; 35(8)3342–3345, [CSA]
- Adamus G, Amundson D. Epitope recognition of recoverin in cancer associated retinopathy: evidence for calcium-dependent conformational epitopes. J Neurosci Res 1996; 45(6)863–872, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Polans A S, Burton M D, Haley T L, et al. Recoverin, but not visinin, is an autoantigen in the human retina identified with a cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34(1)81–90, [PUBMED], [INFOTRIEVE]
- Ohguro H, Nakazawa M. Pathological roles of recoverin in cancer-associated retinopathy. Adv Exp Med Biol 2002; 514: 109–124, (Review)[PUBMED], [INFOTRIEVE], [CSA]
- Thirkill C E, Keltner J L, Tyler N K, Roth A M. Antibody reactions with retina and cancer-associated antigens in 10 patients with cancer-associated retinopathy. Arch Ophthalmol 1993; 111(7)931–937, [PUBMED], [INFOTRIEVE]
- Rose N R, Milgrom F, Van Oss C J. [E. Witebsky; 1901–1906]. Ann Inst Pasteur (Paris) 1970; 119: 555–556
- Witebsky E. Concept of autoimmune disease. Ann NY Acad Sci 1966; 135: 443–450, [PUBMED], [INFOTRIEVE]
- Adamus G. Antirecoverin antibodies and autoimmune retinopathy. Arch Ophthalmol 2000; 118(11)1577–1578, [PUBMED], [INFOTRIEVE], [CSA]
- Adamus G, et al. Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy. J Autoimmun 2003; 21(2)121–129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2003; 2(2)63–68, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J. Neuroimmunol 2002; 132(1–2)72–82, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun Rev 2003; 2(2)63–68, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Adamus G, Machnicki M, Elerding H, et al. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun 1998; 11(5)523–533, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen W, Elias R V, Cao W, et al. Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro. J Neurosci Res 1999; 57(5)706–718, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Drachman D B. How to recognize an antibody-mediated autoimmune disease: criteria. Immunologic mechanisms in neurologic and psychiatric disease, B H Waksman. Raven Press, New York 1990; 183–186
- Meek B, Speijer D, de Jong P T, et al. The ocular humoral immune response in health and disease. Prog Retin Eye Res 2003; 22(3)391–415, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Maeda A, Maeda T, Ohguro H, et al. Vaccination with recoverin, a cancer-associated retinopathy antigen, induces autoimmune retinal dysfunction and tumor cell regression in mice. Eur J Immunol 2002; 32(8)2300–2307, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Agius M A, Richman D P, Fairclough R H, et al. Three forms of immune myasthenia. Ann NY Acad Sci 2003; 998: 453–456, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Richman D P, Agius M A. Treatment principles in the management of autoimmune myasthenia gravis. Ann NY Acad Sci 2003; 998: 457–472, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Roitt I M, Hutchings P R, Dawe K I, et al. The forces driving autoimmune disease. J Autoimmun 1992; 5(Suppl A)11–26, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF]
- Musunuru K, Darnell R B. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu Rev Neurosci 2001; 24: 239–262, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rudnicki S A, Dalmau J. Paraneoplastic syndromes of the spinal cord, nerve, and muscle. Muscle Nerve 2000; 23(12)1800–1818, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Whitcup S M, Vistica B P, Milam A H, et al. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol 1998; 126(2)230–237, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hooks J J, Detrick B, Percopo C, et al. Development and characterization of monoclonal antibodies directed against the retinal pigment epithelial cell. Invest Ophthalmol Vis Sci 1989; 30(10)2106–2113, [PUBMED], [INFOTRIEVE]
- Faure J P, Mirshahi M, Dorey C, et al. Production and specificity of monoclonal antibodies to retinal S antigen. Curr Eye Res 1984; 3(6)867–872, [PUBMED], [INFOTRIEVE]
- Bohle A R, et al. The effect of lubricants on viability of bacillus Calmette-Guerin for intravesical immunotherapy against bladder carcinoma. J Urol 1996; 155(6)1892–1896, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Matsubara S, et al. Expression of the phoreceptor protein recoverin; as a cancer-associated retinopathy autoantigen in human lung cancer cell lines. Br J Cancer 1996; 74(9)1419–1422, [PUBMED], [INFOTRIEVE]
- Matsubara S, et al. Cancer-associated retinopathy syndrome: a case of small cell lung cancer expressing recoverin immunoreactivity. Lung Cancer 1996; 14(2-3)265–271, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yamaji Y, Matsubara S, Yamadori I, et al. Characterization of a small-cell-lung-carcinoma cell line from a patient with cancer-associated retinopathy. Int J Cancer 1996; 65(5)671–676, [PUBMED], [INFOTRIEVE], [CROSSREF]
- McGinnis J F, Lerious V, Pazik J, Elliott R W. Chromosomal assignment of the recoverin gene and cancer-associated retinopathy. Mamm Genome 1993; 4(1)43–45, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- McGinnis J F, Austin B, Klisak I, et al. Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1. J Neurosci Res 1995; 40(2)165–168, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miyagawa Y, Ohguro H, Odagiri H, et al. Aberrantly expressed recoverin is functionally associated with G-protein-coupled receptor kinases in cancer cell lines. Biochem Biophys Res Commun 2003; 300(3)669–673, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Voltz R, et al. A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer. N Engl J Med 1999; 340(23)1788–1795, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gripp S, et al. Thymoma: prognostic factors and treatment outcomes. Cancer 1998; 83(8)1495–1503, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Moll J W, et al. Systemic and anti-neural autoantibodies in patients with paraneoplastic neurological disease. J Neurol 1996; 243(1)51–56, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Verschuuren J J, Dalmau J, Hoard R, Posner J B. Paraneoplastic anti-Hu serum: studies on human tumor cell lines. J Neuroimmunol 1997; 79(2)202–210, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Janeway C A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symp Quant Biol 1989; 54: 1–13, [PUBMED], [INFOTRIEVE]
- Thirkill C E. Experimental, cancer-induced retinopathy. Ocul Immunol Inflamm 1997; 5(1)55–65, [PUBMED], [INFOTRIEVE], [CSA]
- Ohkawa T, Kawashima H, Makino S, et al. Cancer-associated retinopathy in a patient with endometrial cancer. Am J Ophthalmol 1996; 122(5)740–742, [PUBMED], [INFOTRIEVE], [CSA]
- Adamus G, Chan C C. Experimental autoimmune uveitides: multiple antigens; diverse diseases. Int Rev Immunol 2002; 21(2–3)209–229, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Arai J, et al. Tubby-like protein 1 is one of the retinal autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1998; 39(4)3326
- Eichen J G, et al. The photoreceptor cell-specific nuclear receptor is an autoantigen of paraneoplastic retinopathy. J Neuro-Ophthalmol 2001; 21(3)168–172, [CROSSREF], [CSA]
- Ohguro H, et al. Cancer-associated retinopathy induced by both anti-recoverin and anti-hsc70 antibodies in vivo. Invest Ophthalmol Vis Sci 1999; 40(13)3160–3167, [PUBMED], [INFOTRIEVE], [CSA]
- Ohguro H, Ogawa K, Nakagawa T. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci 1999; 40(1)82–89, [PUBMED], [INFOTRIEVE], [CSA]
- Peek R, Dukstra B G, Meek B, Kuijpers A M. Autoantibodies to photoreceptor membrane proteins and outer plexiform layer in patients with cancer-associated retinopathy. Clin Exp Immunol 2002; 128: 498–503, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gregerson D S, Fling S P, Wohlhueter R M. Characterization of immunologically active cyanogen bromide peptide fragments of bovine and human retinal S-antigen. Exp Eye Res 1986; 43: 803–818, [PUBMED], [INFOTRIEVE]
- Gregerson D S, Obritsch W F, Fling S P. Identification of a uveitogenic cyanogen bromide peptide of bovine retinal S-antigen and preparation of a uveitogenic; peptide-specific T cell line. Eur J Immunol 1987; 17: 405–411, [PUBMED], [INFOTRIEVE]
- Gregerson D S, Knospe V, Donoso L A. Selection of antibody epitopes in an immunopathogenic neural autoantigen. J Neuroimmunol. 1989; 24: 191–206, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Dua H S, et al. Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein; phosducin. Curr Eye Res 1992; 11(Suppl)107–111, [PUBMED], [INFOTRIEVE]
- Sergott R C, Brown M J, Silberberg D H, Lisak R P. Antigalactocerebroside serum demyelinates optic nerve in vivo. J Neurol Sci 1984; 64(3)297–303, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sergott R C, Brown M J, Polenta R M, et al. Optic nerve demyelination induced by human serum: patients with multiple sclerosis or optic neuritis and normal subjects. Neurology 1985; 35: 1438–1442, [PUBMED], [INFOTRIEVE]
- Kim Y I. Passively transferred Lambert-Eaton syndrome in mice receiving purified IgG. Muscle Nerve 1986; 9: 523–530, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Buist M R, et al. Radioimmunotargeting in ovarian carcinoma patients with indium-111 labeled monoclonal antibody OV-TL 3 F(ab')2: pharmacokinetics, tissue distribution, and tumor imaging. Int J Gynecol Cancer 1992; 2(1)23–34, [PUBMED], [INFOTRIEVE], [CROSSREF]
- De Bree R, Roos J C, Verel I, et al. Radioimmunodiagnosis of lymph node metastases in head and neck cancer. Oral Dis 2003; 9(5)241–248, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lee F T. SF. Immuno-PET for tumor targeting. J Nucl Med 2003; 44(8)1282–1283, [PUBMED], [INFOTRIEVE]
- Solomon B, et al. Applications of positron emission tomography in the development of molecular targeted cancer therapeutics. BioDrugs. 2003; 17(5)339–354, [PUBMED], [INFOTRIEVE], [CSA]
- Esmaeli B, Koller C, Papadopoulos N, Romaguera J. Interferon-induced retinopathy in asymptomatic cancer patients. Ophthalmology 2001; 108(5)858–860, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Adler R, Curcio C, Hicks D, et al. Cell death in age-related macular degeneration. Mol Vis 1999; 5: 31, (Review)[PUBMED], [INFOTRIEVE], [CSA]
- Kim D M, Koo S Y, Jeon K, et al. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines. Cancer Res 2003; 63(3)621–626, [PUBMED], [INFOTRIEVE]
- Thirkill C E. Retinal pigment epithelial hypersensitivity, an association with vision loss: RPE hypersensitivity complicating paraneoplastic retinopathies. Ocul Immunol Inflamm 2000; 8(1)25–37, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Goldstein S M, Syed N A, Milam A H, et al. Cancer-associated retinopathy. Arch Ophthalmol 1999; 117(12)1641–1645, [PUBMED], [INFOTRIEVE], [CSA]
- Ling C P, Pavesio C. Paraneoplastic syndromes associated with visual loss. Curr Opin Ophthalmol 2003; 14(6)426–432, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kattah J C, Suski E T, Killen J Y, et al. Optic neuritis and systemic lymphoma. Am J Ophthalmol 1980; 89(3)431–436, [PUBMED], [INFOTRIEVE]
- Kraus A M, O'Rourke J. Lymphomatous optic neuritis. Arch Ophthalmol 1963; 70: 173–175, [PUBMED], [INFOTRIEVE]
- Berson E L, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 1988; 106: 307–311, [PUBMED], [INFOTRIEVE]
- Keltner J L, Thirkill C E, Yip P T. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuro-Ophthalmol 2001; 21(3)173–187, (Review)[CROSSREF], [CSA]
- Pfohler C, Haus A, Palmowski A, et al. Melanoma-associated retinopathy: high frequency of subclinical findings in patients with melanoma. Br J Dermatol 2003; 149(1)74–78, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Milam A H, Saari J C, Jacobson S G, et al. Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 1993; 34(1)91–100, [PUBMED], [INFOTRIEVE]
- Singh A D, Milam A H, Shields C L, et al. Melanoma-associated retinopathy. Am J Ophthalmol 1995; 119(3)369–370, [PUBMED], [INFOTRIEVE], [CSA]
- Potter M J, Thirkill C E, Dam O M, et al. Clinical and immunocytochemical findings in a case of melanoma-associated retinopathy. Ophthalmology 1999; 106(11)2121–2125, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Boeck K, Hofmann S, Klopfer M, et al. Melanoma-associated paraneoplastic retinopathy: case report and review of the literature. Br J Dermatol 1997; 137(3)457–460, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF]
- Kellner U, Bornfeld N, Foerster M H. Severe course of cutaneous melanoma associated paraneoplastic retinopathy. Br J Ophthalmol 1995; 79(8)746–752, [PUBMED], [INFOTRIEVE], [CSA]
- Alexander K R, Fishman G A, Peachey N S, et al. ‘On’ response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci 1992; 33: 477–483, [PUBMED], [INFOTRIEVE]
- Osborne N N, Broyden N J, Barnett N L, Morris N J. Protein kinase C (alpha and beta) immunoreactivity in rabbit and rat retina: effect of phorbol esters and transmitter agonists on immunoreactivity and the translocation of the enzyme from cytosolic to membrane compartments. J Neurochem 1991; 57(2)594–604, [PUBMED], [INFOTRIEVE]
- Lei B, Bush R A, Milam A H, Sieving P A. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo. Invest Ophthalmol Vis Sci 2000; 41(1)262–266, [PUBMED], [INFOTRIEVE], [CSA]
- Slingluff C L, Jr, Petroni G R, Yamshchikov G V, et al. Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells. J Clin Oncol 2003; 21(21)4016–4026, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nussenblatt R, et al. Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration. J Autoimmun 2003; 21(3)283–293, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Potter M J, Adamus G, Szabo S M, et al. Autoantibodies to transducin in a patient with melanoma-associated retinopathy. Am J Ophthalmol 2002; 134(1)128–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kozhich A T, Kawano Y, Egwuagu C E, et al. A pathogenic autoimmune process targeted at a surrogate epitope. J Exp Med 1994; 180(1)133–140, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Thirkill C E, Keltner J L, Yip P, Wildberger H, Nickerson J M. Atypical antigen/antibody reaction in melanoma-associated retinopathy (MAR). Ocul Immunol Inflamm 2001; 9(4)277–278, (AUS Meeting abstract)[CROSSREF]
- Keltner J L, Thirkill C E. The 22 kd antigen in optic nerve and retinal diseases. J Neuro-Ophthalmol 1999; 19(2)71–83, [CSA]
- Pfohler C, Thirkill C, Tilgen W. Rosette formation in melanoma: more frequent than suspected?. Am J Dermatopathol 2003; 25(4)360–361, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- To K W, Thirkill C E, Jakobiec F A, Lessell S, Berson E L. Lymphoma-associated retinopathy. Ophthalmology 2002; 109(11)2149–2153, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Susac J O, Lawton-Smith J, O'Powell J O. Carcinomatous optic neuropathy. Am J Ophthalmol 1973; 76: 672–679, [PUBMED], [INFOTRIEVE]
- Anderson N E. Anti-neuronal autoantibodies and neurological paraneoplastic syndromes. Aust NZ J Med 1989; 19: 379–387
- Waterson J A, Gilligan B S. Paraneoplastic optic neuritis and external ophthalmoplegia. Aust NZ J Med 1986; 16: 703–704
- Boghen D, Sebag M, Michaud J. Paraneoplastic optic neuritis and encephalomyelitis. Report of a case. Arch Neurol 1988; 45: 353–356, [PUBMED], [INFOTRIEVE]
- Pillay N, Gilbert J J, Ebers G C, Brown J D. Internuclear ophthalmoplegia and ‘optic neuritis’: paraneoplastic effects of bronchial carcinoma. Neurology 1984; 34(6)788–791, [PUBMED], [INFOTRIEVE]
- Yuki N, Yamada M, Tagawa Y, et al. Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy. J Neurol Sci 1997; 149(2)127–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Scaioli V, et al. Visual evoked potentials findings in course of paclitaxel doxorubicin combination chemotherapy. Report of a case. J Neuro-Oncol 1995; 25(3)221–225, [CROSSREF], [CSA]
- Rubin P, et al. Ocular toxicity following high dose chemotherapy and autologous transplant. Bone Marrow Transplant 1996; 18(1)253–256, [PUBMED], [INFOTRIEVE], [CSA]
- Luiz J E, Lee A, Keltner J L, Thirkill C E, Lai C. Paraneoplastic optic neuropathy and autoantibody production in small cell carcinoma of the lung. J Neuro-Ophthalmol 1998; 18(3)178–181, [CSA]
- Thambisetty M R, Scherzer C R, Yu Z, Lennon V A, Newman N J. Paraneoplastic optic neuropathy and cerebellar ataxia with small cell carcinoma of the lung. J Neuro-Ophthalmol 2001; 21(3)164–167, [CROSSREF], [CSA]
- Cross S A, Salomao D R, Parisi J E, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol 2003; 54(1)38–50, (Review)[PUBMED], [INFOTRIEVE], [CSA]
- Murphy M A, Thirkill C E, Hart W M, Jr. Paraneoplastic retinopathy: a novel autoantibody reaction associated with small-cell lung carcinoma. J Neuro-Ophthalmol 1997; 17(2)77–83, [CSA]
- Honnorat J, Antoine J C, Derrington E, et al. Antibodies to a subpopulation of glial cells and a 66 kDa developmental protein in patients with paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 1996; 61: 270–278, [PUBMED], [INFOTRIEVE], [CSA]
- De l a, Sayette V, Bertran F, Honnorat J, et al. Paraneoplastic cerebellar syndrome and optic neuritis with anti-CV2 antibodies: clinical response to excision of the primary tumor. Arch Neurol 1998; 55(3)405–408, [CROSSREF]
- Anderson N E, Cunningham J M, Posner J B. Autoimmune pathogenesis of paraneoplastic neurological syndromes. Crit Rev Neurobiol 1987; 3: 245–299, [PUBMED], [INFOTRIEVE]
- Anderson N E. Paraneoplastic optic neuritis and external ophthalmoplegia. Australian and New Zealand Journal of Medicine 1987; 17: 539, [PUBMED], [INFOTRIEVE]
- Palmowski A M, et al. Bilateral multifocal chorioretinopathy in a woman with cutaneous malignant melanoma. Arch Ophthalmol 2002; 120(12)1756–1761, [PUBMED], [INFOTRIEVE], [CSA]
- Ross A H, Pleasure D, Sonnenfeld K, et al. Expression of melanoma-associated antigens by normal and neurofibroma Schwann cells. Cancer Res 1986; 46(11)5887–5892, [PUBMED], [INFOTRIEVE]
- Seiter S, Ugurel S, Pfohler C, et al. Successful treatment of progressive vitiligo with high-dose intravenous methylprednisolone ‘pulse’ therapy. Dermatology 1999; 199(3)261–262, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Posner J B. Paraneoplastic syndromes. Curr Neurol 1989; 9: 245–278
- Dalmau J O, Posner J B. Paraneoplastic syndromes affecting the nervous system. Semin Oncol 1997; 24(3)318–328, (Review)[PUBMED], [INFOTRIEVE]
- Posner J B, Dalmau J O. Paraneoplastic syndromes affecting the central nervous system. Annu Rev Med 1997; 48: 157–166, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ohira A, et al. Glial-, neuronal- and photoreceptor-specific cell markers in rosettes of retinoblastoma and retinal dysplasia. Curr Eye Res 1994; 13(11)799–804, [PUBMED], [INFOTRIEVE]
- Paone J P, Jeyasingham K. Remission of cerebellar dysfunction after pneumonectomy for bronchogenic carcinoma. N Engl J Med 1980; 302: 156, [PUBMED], [INFOTRIEVE]
- Gogas J, et al. Granular cell tumor of the breast: a rare lesion resembling breast cancer. Eur J Gynaecol Oncol 2002; 23(4)333–334, [PUBMED], [INFOTRIEVE], [CSA]
- Pruneri G, et al. Follicular dendritic cell sarcoma of the breast. Virchows Arch 2002; 441(2)194–199, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Shibata H, et al. [A case of amelanotic melanoma of the nasal cavity]. Rinsho Byori 2002; 50(7)712–716, (in Japanese, abstract in English)[PUBMED], [INFOTRIEVE], [CSA]
- Shirley S E, et al. Clear cell carcinoma of the breast with immunohistochemical evidence of divergent differentiation. Ann Diagn Pathol 2002; 6(4)250–256, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mitselou A, et al. Immunohistochemical study of the expression of S-100 protein; epithelial membrane antigen; cytokeratin and carcinoembryonic antigen in thyroid lesions. Anticancer Res 2002; 22(3)1777–1780, [PUBMED], [INFOTRIEVE], [CSA]
- Cesinaro A M, et al. ‘Connective tissue nevus’ and a serendipitous s-100 discovery. Am J Dermatopathol 2003; 25(1)86–87, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Molina R, et al. S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function. Tumour Biol. 2002; 23(1)39–44, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gonzalez-Martinez T, et al. S-100 proteins in the human peripheral nervous system. Microsc Res Tech 2003; 60(6)633–638, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kim Y, et al. Acral lentiginous melanoma: an immunohistochemical study of 20 cases. Int J Dermatol 2003; 42(2)123–129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Missotten G S, Tang N E, Korse C M, et al. Prognostic value of S-100-beta serum concentration in patients with uveal melanoma. Arch Ophthalmol 2003; 121(8)1117–1119, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Busam K J, Iversen K, Coplan K C, Jungbluth A A. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol 2001; 25(2)197–204, [PUBMED], [INFOTRIEVE], [CSA]
- Glorieux I, Chabbert V, Rubie H BC, et al. Autoimmune hemolytic anemia associated with a mature ovarian teratoma. Arch Pediatr 1998; 5(1)41–44, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Doldi N, Taccagni G L, Bassan M, et al. Hashimoto's disease in a papillary carcinoma of the thyroid originating in a teratoma of the ovary (malignant struma ovarii). Gynecol Endocrinol 1998; 12(1)41–42, [PUBMED], [INFOTRIEVE], [CSA]
- Farrell D J, Bloxham C A, Scott D J. Hashimoto's disease in a benign cystic teratoma of the ovary. Histopathology 1991; 19(3)283–284, [PUBMED], [INFOTRIEVE]
- Suhler E B, Chan C C, Caruso R C, et al. Presumed teratoma-associated paraneoplastic retinopathy. Arch Ophthalmol 2003; 121(1)133–137, [PUBMED], [INFOTRIEVE], [CSA]
- Shah A, Sadasivan B, Leng B M, Ho J. A teratocarcinoma developing after gross total excision of a pineal teratoma in a patient with systemic lupus erythematosus. Neurol Res 1995; 17(3)229–232, [PUBMED], [INFOTRIEVE], [CSA]
- Labrune B, Habibi B, Courpotin C, et al. Auto-immune haemolytic anaemia and mediastinal dysembryoma in a 6-year-old child (author's transl). Nouv Presse Med 1978; 7(11)921–924, [PUBMED], [INFOTRIEVE]
- Jerne N K. Idiotypic network and other preconceived ideas. Immunol Rev 1984; 79: 5–24, [PUBMED], [INFOTRIEVE], [CSA]
- Singh V K, Yamaki K, Abe T, Shinohara T. Molecular mimicry between uveitopathogenic site of retinal S–antigen and Escherichia Coli protein: induction of experimental autoimmune uveitis and lymphocyte cross–reaction. Cell Immunol 1989; 122(1)262–273, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gregerson D S, Obritsch W F, Donoso L. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols. J Immunol 1993; 151(10)5751–5761, [PUBMED], [INFOTRIEVE]
- Nussenblatt R B, et al. Strategies for the treatment of intraocular inflammatory disease. Transplant Proc 1998; 30(8)4124–4125, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sulzer B, Van Hemmen J L, Behn U. Central immune system, the self and autoimmunity. Bull Math Biol 1994; 56(6)1009–1040, [PUBMED], [INFOTRIEVE], [CSA]
- Vassilev T, et al. Normal human immunoglobulin suppresses experimental myasthenia gravis in SCID mice. Eur J Immunol 1999; 29(8)2436–2442, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bataller L, Dalmau J. Paraneoplastic neurologic syndromes: approaches to diagnosis and treatment. Semin Neurol 2003; 23(2)215–224, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF]
- Donofrio P D. Immunotherapy of idiopathic inflammatory neuropathies. Muscle Nerve 2003; 28(3)273–292, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- De Kozak Y. Regulation of retinal autoimmunity via the idiotypic network. Curr Eye Res 1990; 9(Suppl)193–200, [PUBMED], [INFOTRIEVE]
- Roitt I M, Cooke A. Manipulation of idiotype networks in autoimmunity. Ciba Found Symp 1987; 29: 209–222, (Review)
- Zanetti M, Rogers J, Katz D H. Perturbation of the autoimmune network. I. Immunization with anti-idiotypic antibodies prior to challenge with antigen induces quantitative variations in the autoantibody response. Autoimmunity 1988; 1(1)23–36, [PUBMED], [INFOTRIEVE]
- Whitcup S M, De Barge L R, Caspi R R, et al. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin Immunol Immunopathol 1993; 67(2)143–150, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rao N A, Atalla L, Linker-Israeli M, et al. Suppression of experimental uveitis in rats by anti-I-A antibodies. Invest Ophthalmol Vis Sci 1989; 30(11)2348–2355, [PUBMED], [INFOTRIEVE]
- De Kozak Y, Mirshahi M, Boucheix C, Faure J P. Inhibition of S-antigen-induced experimental autoimmune uveoretinitis by active immunization against anti-idiotypic antibody to an S-antigen epitope. Reg Immunol 1992; 4(3)168–174, [PUBMED], [INFOTRIEVE]
- De Kozak Y, Stiemer R H, Mirshahi M, et al. Humoral immune response against the S-antigen/TNF alpha common epitope in rat EAU suppressed by the monoclonal antibody S2D2. Curr Eye Res 1992; 11(Suppl)119–127, [PUBMED], [INFOTRIEVE]
- Caress J B, Cartwright M S, Donofrio P D, Peacock J E, Jr. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 2003; 60(11)1822–1824, [PUBMED], [INFOTRIEVE]
- Eibl M M. Intravenous immunoglobulins in neurological disorders: safety issues. Neurol Sci 2003; 24(Suppl 4)S222–226, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF]
- Wittstock M, Benecke R, Zettl U K. Therapy with intravenous immunoglobulins: complications and side-effects. Eur Neurol 2003; 50(3)172–175, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kodama S, Kuhtreiber W, Fujimura S, et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003; 302(5648)1223–1227, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Larsson K, Lonnqvist B, Ringden O, et al. CMV retinitis after allogeneic bone marrow transplantation: a report of five cases. Transplant Infect Dis 2002; 4(2)75–79, [CROSSREF], [CSA]
- Adamus G, Sugden B, Shiraga S, et al. Anti-apoptotic effects of CNTF gene transfer on photoreceptor degeneration in experimental antibody-induced retinopathy. J Autoimmun 2003; 21(2)121–129, [PUBMED], [INFOTRIEVE], [CSA]
- Hauswirth W W, Beaufrere L. Ocular gene therapy: quo vadis?. Invest Ophthalmol Vis Sci 2000; 41(10)2821–2826, [PUBMED], [INFOTRIEVE], [CSA]
- Zhu C ZY, Pardridge W M. Widespread expression of an exogenous gene in the eye after intravenous administration. Invest Ophthalmol Vis Sci 2002; 43: 3075–3080, [PUBMED], [INFOTRIEVE], [CSA]
- Zhang Y, Schlachetzki F, Li J Y, et al. Organ-specific gene expression in the rhesus monkey eye following intravenous non-viral gene transfer. Mol Vis 2003; 9: 465–472, [PUBMED], [INFOTRIEVE]
- Hauswirth W W, McInnes R R. Retinal gene therapy 1998: summary of a workshop. Mol Vis 1998; 4: 11, [PUBMED], [INFOTRIEVE], [CSA]
- Zhang L, Jayne D R, Oliveira D B. Anti-idiotype antibodies to anti-mitochondrial antibodies in the sera of patients with primary biliary cirrhosis. J Autoimmun 1993; 6(1)93–105, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Caspi R R, Roberge F G, Chan C C, et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 1988; 140: 1490–1495, [PUBMED], [INFOTRIEVE]
- Caspi R R, Silver P B, Chan C C, et al. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th1 response. J Immunol 1996; 157(6)2668–2675, [PUBMED], [INFOTRIEVE]
- Kaye F J. Molecular biology of lung cancer. Lung Cancer 2001; 34(Suppl 2)S35–41, (Review)[PUBMED], [INFOTRIEVE], [CROSSREF]
- Pinarbasi H, Silig Y, Cetinkaya O, et al. Strong association between the GSTM1-null genotype and lung cancer in a Turkish population. Cancer Genet Cytogenet 2003; 146(2)125–129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]